title: Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?
authors.affiliation: Pharmacy Department, University Hospital 12 Octubre, Avda. Cordoba s/n., 28041 Madrid, Spain. Electronic address: Irene.canamares@gmail.com.
authors.forename: Irene
authors.initials: I
authors.lastname: Cañamares-Orbis
authors.affiliation: Infectious Diseases Unit, University Hospital 12 Octubre, Madrid, Spain.
authors.forename: José Tiago
authors.initials: JT
authors.lastname: Silva
authors.affiliation: Infectious Diseases Unit, University Hospital 12 Octubre, Madrid, Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: López-Medrano
authors.affiliation: Infectious Diseases Unit, University Hospital 12 Octubre, Madrid, Spain.
authors.forename: Jose Maria
authors.initials: JM
authors.lastname: Aguado
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000209:etiology; D001281:Atrial Fibrillation / Q000150:complications; D017576:Daptomycin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000209:etiology; D004697:Endocarditis, Bacterial / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005578:Fosfomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006333:Heart Failure / Q000139:chemically induced*; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D016459:Prosthesis-Related Infections / Q000188:drug therapy*; D012964:Sodium / Q000008:administration & dosage / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D012964:Sodium; D017576:Daptomycin